The role of nicotinic acetylcholine receptors in Alzheimer's disease

Journal of Physiology Paris

Volumn 99, Issue 2-3, 2006, Pages 172-179

  Oddo, Salvatore ^a   LaFerla, Frank M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

A ; Nicotine; Plaques; Tangles; Tau; Transgenic

Indexed keywords

AMYLOID BETA PROTEIN; CHOLINESTERASE INHIBITOR; NICOTINE; NICOTINE GUM; NICOTINE PATCH; NICOTINIC RECEPTOR; TAU PROTEIN;

ALZHEIMER DISEASE; BRAIN CORTEX; CELL INCLUSION; CHOLINERGIC NERVE CELL; CLINICAL TRIAL; COGNITIVE DEFECT; CONFERENCE PAPER; HIPPOCAMPUS; HUMAN; NEUROBIOLOGY; NEUROCHEMISTRY; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NONHUMAN; PLAQUE FORMING CELL; PROTEIN AGGREGATION; PROTEIN PHOSPHORYLATION; RECEPTOR INTRINSIC ACTIVITY; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; HUMANS; ION CHANNEL GATING; NICOTINE; RECEPTORS, NICOTINIC; TAU PROTEINS;

EID: 33645026907     PISSN: 09284257     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jphysparis.2005.12.080     Document Type: Conference Paper

References (69)

1. O.P. Almeida, G.K. Hulse, D. Lawrence, and L. Flicker Smoking as a risk factor for Alzheimer's disease: contrasting evidence from a systematic review of case-control and cohort studies Addiction 97 2002 15 28
2. L. Aubert, D.M. Araujo, D. Cecyre, Y. Robitaille, S. Gauthier, and R. Quirion Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases J. Neurochem. 58 1992 529 541
3. L.M. Billings, S. Oddo, K.N. Green, J.L. McGaugh, and F.M. Laferla Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice Neuron 45 2005 675 688
4. L. Burghaus, U. Schutz, U. Krempel, R.A. de Vos, E.N. Jansen Steur, A. Wevers, J. Lindstrom, and H. Schroder Quantitative assessment of nicotinic acetylcholine receptor proteins in the cerebral cortex of Alzheimer patients Brain Res. Mol. Brain Res. 76 2000 385 388
5. J.A. Court, M. Johnson, D. Religa, J. Keverne, R. Kalaria, E. Jaros, I.G. McKeith, R. Perry, J. Naslund, and E.K. Perry Attenuation of Abeta deposition in the entorhinal cortex of normal elderly individuals associated with tobacco smoking Neuropathol. Appl. Neurobiol. 31 2005 522 535
6. P. Davies, and A.J. Maloney Selective loss of central cholinergic neurons in Alzheimer's disease Lancet 2 1976 1403
7. K.T. Dineley, M. Westerman, D. Bui, K. Bell, K.H. Ashe, and J.D. Sweatt Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: in vitro and in vivo mechanisms related to Alzheimer's disease J. Neurosci. 21 2001 4125 4133
8. D. Flynn, and D.C. Mash Characterization of L-[3H]nicotine binding in human cerebral cortex: comparison between Alzheimer's disease and the normal J. Neurochem. 47 1986 1948 1954
9. L.R. Fodero, S.S. Mok, D. Losic, L.L. Martin, M.I. Aguilar, C.J. Barrow, B.G. Livett, and D.H. Small Alpha 7-nicotinic acetylcholine receptors mediate an Abeta(1-42)-induced increase in the level of acetylcholinesterase in primary cortical neurones J. Neurochem. 88 2004 1186 1193
10. C.J. Frazier, A.V. Buhler, J.L. Weiner, and T.V. Dunwiddie Synaptic potentials mediated via alpha-bungarotoxin-sensitive nicotinic acetylcholine receptors in rat hippocampal interneurons J. Neurosci. 18 1998 8228 8235
11. D.B. Freir, C. Holscher, and C.E. Herron Blockade of long-term potentiation by beta-amyloid peptides in the CA1 region of the rat hippocampus in vivo J. Neurophysiol. 85 2001 708 713
12. C. Gotti, and F. Clementi Neuronal nicotinic receptors: from structure to pathology Prog. Neurobiol. 74 2004 363 396
13. E. Hellstrom-Lindahl, M. Mousavi, X. Zhang, R. Ravid, and A. Nordberg Regional distribution of nicotinic receptor subunit mRNAs in human brain: comparison between Alzheimer and normal brain Brain. Res. Mol. Brain. Res. 66 1999 94 103
14. E. Hellstrom-Lindahl, H. Moore, and A. Nordberg Increased levels of tau protein in SH-SY5Y cells after treatment with cholinesterase inhibitors and nicotinic agonists J. Neurochem. 74 2000 777 784
15. E. Hellstrom-Lindahl, J. Court, J. Keverne, M. Svedberg, M. Lee, A. Marutle, A. Thomas, E. Perry, I. Bednar, and A. Nordberg Nicotine reduces A beta in the brain and cerebral vessels of APPsw mice Eur. J. Neurosci. 19 2004 2703 2710
16. M.N. Howe, and I.R. Price Effects of transdermal nicotine on learning, memory, verbal fluency, concentration, and general health in a healthy sample at risk for dementia Int. Psychogeriatr. 13 2001 465 475
17. K. Hsiao, P. Chapman, S. Nilsen, C. Eckman, Y. Harigaya, S. Younkin, F. Yang, and G. Cole Correlative memory deficits, abeta elevation, and amyloid plaques in transgenic mice Science 274 1996 99 102
18. D. Ji, R. Lape, and J.A. Dani Timing and location of nicotinic activity enhances or depresses hippocampal synaptic plasticity Neuron 31 2001 131 141
19. G.M. Jones, B.J. Sahakian, R. Levy, D.M. Warburton, and J.A. Gray Effects of acute subcutaneous nicotine on attention information processing and short-term memory in Alzheimer's disease Psychopharmacol. (Berl.) 108 1992 485 494
20. D. Juan, D.H. Zhou, J. Li, J.Y. Wang, C. Gao, and M. Chen A 2-year follow-up study of cigarette smoking and risk of dementia Eur. J. Neurol. 11 2004 277 282
21. A. Karlin Emerging structure of the nicotinic acetylcholine receptors Nat. Rev. Neurosci. 3 2002 102 114
22. T. Kihara, S. Shimohama, M. Urushitani, H. Sawada, J. Kimura, T. Kume, T. Maeda, and A. Akaike Stimulation of alpha4beta2 nicotinic acetylcholine receptors inhibits beta-amyloid toxicity Brain Res. 792 1998 331 334
23. M. Kitazawa, S. Oddo, T.R. Yamasaki, K.N. Green, and F.M. LaFerla Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease J. Neurosci. 25 39 2005 8843 8853
24. W.A. Kukull The association between smoking and Alzheimer's disease: effects of study design and bias Biol. Psychiat. 49 2001 194 199
25. M.A. Lambon Ralph, K. Patterson, N. Graham, K. Dawson, and J.R. Hodges Homogeneity and heterogeneity in mild cognitive impairment and Alzheimer's disease: a cross-sectional and longitudinal study of 55 cases Brain 126 2003 2350 2362
26. L. Letenneur, S. Larrieu, and P. Barberger-Gateau Alcohol and tobacco consumption as risk factors of dementia: a review of epidemiological studies Biomed. Pharmacother. 58 2004 95 99
27. J. Lindstrom Nicotinic acetylcholine receptors in health and disease Mol. Neurobiol. 15 1997 193 222
28. Q. Liu, H. Kawai, and D.K. Berg Beta-amyloid peptide blocks the response of alpha 7-containing nicotinic receptors on hippocampal neurons Proc. Natl. Acad. Sci. USA 98 2001 4734 4739
29. C.M. Martin-Ruiz, J.A. Court, E. Molnar, M. Lee, C. Gotti, A. Mamalaki, T. Tsouloufis, S. Tzartos, C. Ballard, R.H. Perry, and E.K. Perry Alpha4 but not alpha3 and alpha7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease J. Neurochem. 73 1999 1635 1640
30. A. Marutle, U. Warpman, N. Bogdanovic, L. Lannfelt, A. Nordberg, and A. Neuronal nicotinic receptor deficits in Alzheimer patients with the Swedish amyloid precursor protein 670/671 mutation J. Neurochem. 72 1999 1161 1169
31. P.L. McGeer, E.G. McGeer, J. Suzuki, C.E. Dolman, and T. Nagai Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain Neurology 34 1984 741 745
32. D.S. McGehee, M.J. Heath, S. Gelber, P. Devay, and L.W. Role Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors Science 269 1995 1692 1696
33. D.M. Morens, A. Grandinetti, D. Reed, and L.R. White Smoking-associated protection from Alzheimer's and Parkinson's disease Lancet 343 1994 356 357
34. M. Mousavi, E. Hellstrom-Lindahl, Z.Z. Guan, K.R. Shan, R. Ravid, and A. Nordberg Protein and mRNA levels of nicotinic receptors in brain of tobacco using controls and patients with Alzheimer's disease Neuroscience 122 2003 515 520
35. J.L. Muir Acetylcholine, aging, and Alzheimer's disease Pharmacol. Biochem. Behav. 56 1997 687 696
36. P.A. Newhouse, T. Sunderland, P.N. Tariot, C.L. Blumhardt, H. Weingartner, A. Mellow, and D.L. Murphy Intravenous nicotine in Alzheimer's disease: a pilot study Psychopharmacol. (Berl.) 95 1988 171 175
37. A. Nordberg, A. Adem, J. Hardy, and B. Winblad Change in nicotinic receptor subtypes in temporal cortex of Alzheimer brains Neurosci. Lett. 86 1988 317 321
38. A. Nordberg, P. Hartvig, A. Lilja, M. Viitanen, K. Amberla, H. Lundqvist, Y. Andersson, J. Ulin, B. Winblad, and B. Langstrom Decreased uptake and binding of 11C-nicotine in brain of Alzheimer patients as visualized by positron emission tomography J. Neural. Transm. Park. Dis. Dement. Sect. 2 1990 215 224
39. A. Nordberg, H. Lundqvist, P. Hartvig, A. Lilja, and B. Langstrom Kinetic analysis of regional (S)(-)11C-nicotine binding in normal and Alzheimer brains-in vivo assessment using positron emission tomography Alzheimer. Dis. Assoc. Disord. 9 1995 21 27
40. A. Nordberg, H. Lundqvist, P. Hartvig, J. Andersson, M. Johansson, E. Hellstrom-Lindahi, and B. Langstrom Imaging of nicotinic and muscarinic receptors in Alzheimer's disease: effect of tacrine treatment Dement. Geriatr. Cogn. Disord. 8 1997 78 84
41. A. Nordberg, E. Hellstrom-Lindahl, M. Lee, M. Johnson, M. Mousavi, R. Hall, E. Perry, I. Bednar, and J. Court Chronic nicotine treatment reduces beta-amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw) J. Neurochem. 81 2002 655 658
42. A. Nordberg, and B. Winblad Reduced number of [3H]nicotine and [3H]acetylcholine binding sites in the frontal cortex of Alzheimer brains Neurosci. Lett. 72 1986 115 119
43. S. Oddo, A. Caccamo, J.D. Shepherd, M.P. Murphy, T.E. Golde, R. Kayed, R. Metherate, M.P. Mattson, Y. Akbari, and F.M. LaFerla Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction Neuron 39 2003 409 421
44. S. Oddo, A. Caccamo, K.N. Green, K. Liang, L. Tran, Y. Chen, F.M. Leslie, and F.M. LaFerla Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease Proc. Natl. Acad. Sci. USA 102 2005 3046 3051
45. K. Ono, K. Hasegawa, M. Yamada, and H. Naiki Nicotine breaks down preformed Alzheimer's beta-amyloid fibrils in vitro Biol. Psychiat. 52 2002 880 886
46. A. Ott, K. Andersen, M.E. Dewey, L. Letenneur, C. Brayne, J.R. Copeland, J.F. Dartigues, P. Kragh-Sorensen, A. Lobo, J.M. Martinez-Lage, T. Stijnen, A. Hofman, and L.J. Launer Effect of smoking on global cognitive function in nondemented elderly Neurology 62 2004 920 924
47. R.W. Parks, R.E. Becker, R.F. Rippey, D.G. Gilbert, J.R. Matthews, E. Kabatay, C.S. Young, C. Vohs, V. Danz, P. Keim, G.T. Collins, S.S. Zigler, and P.G. Urycki Increased regional cerebral glucose metabolism and semantic memory performance in Alzheimer's disease: a pilot double blind transdermal nicotine positron emission tomography study Neuropsychol. Rev. 6 1996 61 79
48. E.K. Perry, C.J. Smith, J.A. Court, and R.H. Perry Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types J. Neural. Transm. Park. Dis. Dement. Sect. 2 1990 149 158
49. E.K. Perry, C.M. Morris, J.A. Court, A. Cheng, A.F. Fairbairn, I.G. McKeith, D. Irving, A. Brown, and R.H. Perry Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology Neuroscience 64 1995 385 395
50. S.C. Provost, and R. Woodward Effects of nicotine gum on repeated administration of the Stroop test Psychopharmacol. (Berl.) 104 1991 536 540
51. J.O. Rinne, T. Myllykyla, P. Lonnberg, and P. Marjamaki A postmortem study of brain nicotinic receptors in Parkinson's and Alzheimer's disease Brain Res. 547 1991 167 170
52. M.N. Sabbagh, S.L. Tyas, S.C. Emery, L.A. Hansen, M.F. Alford, R.T. Reid, P. Tiraboschi, and L.J. Thal Smoking affects the phenotype of Alzheimer disease Neurology 64 2005 1301 1303
53. B. Sahakian, G. Jones, R. Levy, J. Gray, and D. Warburton The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type Br. J. Psychiat. 154 1989 797 800
54. A.R. Salomon, K.J. Marcinowski, R.P. Friedland, and M.G. Zagorski Nicotine inhibits amyloid formation by the beta-peptide Biochemistry 35 1996 13568 13578
55. S. Shimohama, T. Taniguchi, M. Fujiwara, and M. Kameyama Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia J. Neurochem. 46 1986 288 293
56. J. Snaedal, T. Johannesson, J.E. Jonsson, and G. Gylfadottir The effects of nicotine in dermal plaster on cognitive functions in patients with Alzheimer's disease Dementia 7 1996 47 52
57. D.L. Sparks, T.G. Beach, and R.J. Lukas Immunohistochemical localization of nicotinic beta2 and alpha4 receptor subunits in normal human brain and individuals with Lewy body and Alzheimer's disease: preliminary observations Neurosci. Lett. 256 1998 151 154
58. K. Sugaya, E. Giacobini, and V.A. Chiappinelli Nicotinic acetylcholine receptor subtypes in human frontal cortex: changes in Alzheimer's disease J. Neurosci. Res. 27 1990 349 359
59. S. Terzano, J.A. Court, D. Fornasari, M. Griffiths, D.P. Spurden, S. Lloyd, R.H. Perry, E.K. Perry, and F. Clementi Expression of the alpha3 nicotinic receptor subunit mRNA in aging and Alzheimer's disease Brain Res. Mol. Brain Res. 63 1998 72 78
60. S.L. Tyas, L.R. White, H. Petrovitch, G. Webster Ross, D.J. Foley, H.K. Heimovitz, and L.J. Launer Mid-life smoking and late-life dementia the Honolulu-Asia Aging Study Neurobiol. Aging 24 2003 589 596
61. J. Ulrich, G. Johannson-Locher, W.O. Seiler, and H.B. Stahelin Does smoking protect from Alzheimer's disease? Alzheimer-type changes in 301 unselected brains from patients with known smoking history Acta. Neuropathol. (Berl.) 94 1997 450 454
62. H.X. Wang, L. Fratiglioni, G.B. Frisoni, M. Viitanen, and B. Winblad Smoking and the occurrence of Alzheimer's disease: cross-sectional and longitudinal data in a population-based study Am. J. Epidemiol. 149 1999 640 644
63. H.Y. Wang, D.H. Lee, M.R. D'Andrea, P.A. Peterson, R.P. Shank, and A.B. Reitz Beta-Amyloid (1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology J. Biol. Chem. 275 2000 5626 5632
64. H.Y. Wang, W. Li, N.J. Benedetti, and D.H. Lee Alpha 7 nicotinic acetylcholine receptors mediate beta-amyloid peptide-induced tau protein phosphorylation J. Biol. Chem. 278 2003 31547 31553
65. A. Wevers, L. Monteggia, S. Nowacki, W. Bloch, U. Schutz, J. Lindstrom, E.F. Pereira, H. Eisenberg, E. Giacobini, R.A. de Vos, E.N. Steur, A. Maelicke, E.X. Albuquerque, and H. Schroder Expression of nicotinic acetylcholine receptor subunits in the cerebral cortex in Alzheimer's disease: histotopographical correlation with amyloid plaques and hyperphosphorylated-tau protein Eur. J. Neurosci. 11 1999 2551 2565
66. A. Wevers, and H. Schroder Nicotinic acetylcholine receptors in Alzheimer's disease J. Alzheimers Dis. 1 1999 207 219
67. H.K. White, and E.D. Levin Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease Psychopharmacol. (Berl.) 143 1999 158 165
68. A.L. Wilson, L.K. Langley, J. Monley, T. Bauer, S. Rottunda, E. McFalls, C. Kovera, and J.R. McCarten Nicotine patches in Alzheimer's disease: pilot study on learning, memory, and safety Pharmacol. Biochem. Behav. 51 1995 509 514
69. N.J. Woolf The critical role of cholinergic basal forebrain neurons in morphological change and memory encoding: a hypothesis Neurobiol. Learn. Mem. 66 1996 258 266